Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

This study has been completed.
Information provided by (Responsible Party):
MEI Pharma, Inc. Identifier:
First received: September 7, 2004
Last updated: July 13, 2016
Last verified: July 2016